Literature DB >> 7531335

The significance of CD44 in human pancreatic cancer: II. The role of CD44 in human pancreatic adenocarcinoma invasion.

M Takada1, M Yamamoto, Y Saitoh.   

Abstract

In our previous report (1), we showed the high expression of CD44 in human pancreatic adenocarcinomas cells. Pancreatic cancer aggressively invades surrounding tissues by penetrating basement membrane barriers. To examine the relation between the biological characteristics of human pancreatic adenocarcinoma cells and CD44 expression, we studied the function of CD44 in cell proliferation and cell invasion using a Matrigel basement membrane. The proliferation of human pancreatic adenocarcinoma cells was not affected by anti-CD44 antibody. On the contrary, invasion of the cells was suppressed by anti-CD44 antibody. This result suggests that the CD44 molecule plays an important role in pancreatic cancer cell invasion of the basement membrane.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7531335     DOI: 10.1097/00006676-199411000-00014

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  8 in total

Review 1.  CD44 and the adhesion of neoplastic cells.

Authors:  Z Rudzki; S Jothy
Journal:  Mol Pathol       Date:  1997-04

2.  CD44 exon 6 expression as a possible early prognostic factor in primary node negative breast carcinoma.

Authors:  N Guriec; L Marcellin; B Gairard; H Caldéroli; A Wilk; R Renaud; J P Bergerat; F Oberling
Journal:  Clin Exp Metastasis       Date:  1996-10       Impact factor: 5.150

3.  Differential expression of CD44v6 in adenocarcinoma of the pancreas: an immunohistochemical study.

Authors:  E M Castellà; A Ariza; I Ojanguren; J L Mate; X Roca; A Fernández-Vasalo; J J Navas-Palacios
Journal:  Virchows Arch       Date:  1996-11       Impact factor: 4.064

Review 4.  Pancreatic adenocarcinoma: epidemiology and genetics.

Authors:  T Y Flanders; W D Foulkes
Journal:  J Med Genet       Date:  1996-11       Impact factor: 6.318

5.  CRABP-II is a highly sensitive and specific diagnostic molecular marker for pancreatic ductal adenocarcinoma in distinguishing from benign pancreatic conditions.

Authors:  Wenbin Xiao; Hong Hong; Amad Awadallah; Shuiliang Yu; Lan Zhou; Wei Xin
Journal:  Hum Pathol       Date:  2014-01-31       Impact factor: 3.466

Review 6.  Role of hyaluronan in pancreatic cancer biology and therapy: Once again in the spotlight.

Authors:  Norihiro Sato; Shiro Kohi; Keiji Hirata; Michael Goggins
Journal:  Cancer Sci       Date:  2016-03-18       Impact factor: 6.716

Review 7.  Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma.

Authors:  Norihiro Sato; Xiao-Bo Cheng; Shiro Kohi; Atsuhiro Koga; Keiji Hirata
Journal:  Acta Pharm Sin B       Date:  2016-01-21       Impact factor: 11.413

8.  Antitumor effects of the hyaluronan inhibitor 4-methylumbelliferone on pancreatic cancer.

Authors:  Eri Yoshida; Daisuke Kudo; Hayato Nagase; Hiroshi Shimoda; Shinichiro Suto; Mika Negishi; Ikuko Kakizaki; Masahiko Endo; Kenichi Hakamada
Journal:  Oncol Lett       Date:  2016-08-02       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.